- INO has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $14.8 million.
- INO has traded 512,907 shares today.
- INO is up 3% today.
- INO was down 9.9% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in INO with the Ticky from Trade-Ideas. See the FREE profile for INO NOW at Trade-Ideas More details on INO: Inovio Pharmaceuticals, Inc., together with its subsidiaries, discovers, develops, and develops synthetic vaccines and immune therapies focusing on cancers and infectious diseases. Currently there are 5 analysts that rate Inovio Pharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Inovio Pharmaceuticals has been 1.9 million shares per day over the past 30 days. Inovio has a market cap of $599.2 million and is part of the health care sector and drugs industry. The stock has a beta of 3.38 and a short float of 14% with 7.05 days to cover. Shares are down 22.7% year-to-date as of the close of trading on Monday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.